Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen

被引:54
|
作者
Apt, D
Raviprakash, K
Brinkman, A
Semyonov, A
Yang, SM
Skinner, C
Diehl, L
Lyons, R
Porter, K
Punnonen, J
机构
[1] Maxygen Inc, Human Therapeut, Redwood City, CA 94063 USA
[2] USN, Med Res Ctr, Viral Dis Dept, Silver Spring, MD 20910 USA
[3] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA
关键词
dengue virus; antigen; tetravalent; multivalent antigen; DNA shuffling; cross-neutralizing antibodies;
D O I
10.1016/j.vaccine.2005.07.100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We employed DNA shuffling and screening technologies to develop a single recombinant dengue envelope (E) antigen capable of inducing neutralizing antibodies against all four antigenically distinct dengue serotypes. By DNA shuffling of codon-optimized dengue 1-4 E genes, we created a panel of novel chimeric clones expressing C-terminal truncated E antigens that combined epitopes from all four dengue serotypes. DNA vaccines encoding these novel chimeras induced multivalent T cell and neutralizing antibody responses against all four dengue serotypes in mice. By contrast, a mixture of four unshuffled, parental DNA vaccines failed to produce tetravalent neutralizing antibodies in mice. length neutralizing antibody titers for some of these antigens could be further improved by extending the sequences to express full membrane and envelope proteins. The chimeric antigens also protected mice against a lethal dengue-2 virus challenge. These data demonstrate that DNA shuffling and associated screening can lead to the selection of multi-epitope antigens against closely related dengue virus serotypes and suggest a broad utility for these technologies in optimizing vaccine antigens. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:335 / 344
页数:10
相关论文
共 50 条
  • [31] Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera
    Batra, Gaurav
    Nemani, Satish K.
    Tyagi, Poornima
    Swaminathan, Sathyamangalam
    Khanna, Navin
    BMC INFECTIOUS DISEASES, 2011, 11
  • [32] CHARACTERIZATION OF THE NEUTRALIZING ANTIBODY RESPONSE IN BASELINE SERONEGATIVE CHILDREN, ADOLESCENT AND ADULT RECIPIENTS OF A TETRAVALENT DENGUE VACCINE
    Zahralban-Steele, Melissa
    Kaiser, Maima
    Rindfleisch, Tim
    Bohning, Kelly
    Norwood, Brooke
    Dominguez, David
    DeMaso, Christina
    Sharma, Mayuri
    Dean, Hansi
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 51 - 51
  • [33] Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virus
    Pitaksajjakul, Pannamthip
    Benjathummarak, Surachet
    Pipattanaboon, Chonlatip
    Wongwit, Waranya
    Okabayashi, Tamaki
    Kuhara, Motoki
    Misaki, Ryo
    Fujiyama, Kazuhito
    Ramasoota, Pongrama
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 446 (02) : 475 - 480
  • [34] Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays
    Yamanaka, Atsushi
    Suzuki, Ryosuke
    Konishi, Eiji
    VACCINE, 2014, 32 (34) : 4289 - 4295
  • [35] Tetravalent Virus-like Particles Engineered To Display Envelope Domain IIIs of Four Dengue Serotypes in Silkworm as Vaccine Candidates
    Muthuraman, Krishna Raja
    Boonyakida, Jirayu
    Matsuda, Mami
    Suzuki, Ryosuke
    Kato, Tatsuya
    Park, Enoch Y.
    BIOMACROMOLECULES, 2025, 26 (03) : 2003 - 2013
  • [36] SINGLE ADMINISTRATION OF LIVE-ATTENUATED TETRAVALENT DENGUE VACCINE CANDIDATE, KD-382, INDUCED LONG-LASTING (>2 YEARS) NEUTRALIZING ANTIBODY AGAINST ALL FOUR SEROTYPES IN CYNOMOLGUS MONKEYS
    Shinmura, Yasuhiko
    Takagi, Shota
    Yoshimura, Masaya
    Kameyama, Kazuhisa
    Sonoda, Kengo
    Kino, Yoichiro
    Yoksan, Sutee
    Fujii, Takashi
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 246 - 246
  • [37] Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes
    Khanam, S
    Etemad, B
    Khanna, N
    Swaminathan, S
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 74 (02): : 266 - 277
  • [38] Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes
    Leon-Juarez, Moises
    Garcia-Cordero, Julio
    Santos-Argumedo, Leopoldo
    Romero-Ramirez, Hector
    Garcia-Machorro, Jazmin
    Bustos-Arriaga, Jose
    Gutierrez-Castaneda, Benito
    Sepulveda, Nicolas V.
    Mellado-Sanchez, Gabriela
    Cedillo-Barron, Leticia
    APMIS, 2013, 121 (09) : 848 - 858
  • [39] Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand
    Thomas, Rasmi
    Chansinghakul, Danaya
    Limkittikul, Kriengsak
    Gilbert, Peter B.
    Hattasingh, Weerawan
    Moodie, Zoe
    Shangguan, Shida
    Frago, Carina
    Dulyachai, Wut
    Li, Shuying Sue
    Jarman, Richard G.
    Geretz, Aviva
    Bouckenooghe, Alain
    Sabchareon, Arunee
    Juraska, Michal
    Ehrenberg, Philip
    Michael, Nelson L.
    Bailleux, Fabrice
    Bryant, Chris
    Gurunathan, Sanjay
    HUMAN IMMUNOLOGY, 2022, 83 (01) : 53 - 60
  • [40] On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes
    Rajamanonmani, Ravikumar
    Nkenfou, Celine
    Clancy, Paula
    Yau, Yin Hoe
    Shochat, Susana Geifman
    Sukupolvi-Petty, Sob
    Schul, Wouter
    Diamond, Michael S.
    Vasudevan, Subhash G.
    Lescar, Julien
    JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 799 - 809